Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence
出版年份 2023 全文链接
标题
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2023-11-06
DOI
10.1093/schbul/sbad145
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Who has poor insight, my patient suffering from schizophrenia or myself?
- (2023) Michael Davidson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
- (2022) Johannes Schneider-Thoma et al. LANCET
- Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline
- (2022) R.M. Murray et al. SCHIZOPHRENIA RESEARCH
- Associating Violence With Schizophrenia—Risks and Biases
- (2022) Paolo Fusar-Poli et al. JAMA Psychiatry
- Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
- (2022) Christoph U. Correll et al. npj Schizophrenia
- Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis
- (2022) Frank Buttgereit et al. RHEUMATOLOGY
- Deinstitutionalization and the Impact of Antipsychotics Versus Policy Change
- (2022) Joni Lee Pow et al. Ethical Human Psychology and Psychiatry
- Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials
- (2022) Jan P A M Bogers et al. SCHIZOPHRENIA BULLETIN
- Long-term impact of antipsychotics: settling the controversy requires more clarity
- (2021) Awais Aftab PSYCHOLOGICAL MEDICINE
- A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
- (2021) Mark Abie Horowitz et al. SCHIZOPHRENIA BULLETIN
- Misreporting of Results of Research in Psychiatry
- (2021) Jana Bowcut et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic-induced supersensitivity – A reappraisal
- (2021) William Lugg AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Long-term effectiveness of antipsychotics
- (2021) Martin Harrow et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic discontinuation and recovery: chicken or egg?
- (2021) Joseph M. Pierre et al. PSYCHOLOGICAL MEDICINE
- How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size Indices
- (2021) Stefan Leucht et al. SCHIZOPHRENIA BULLETIN
- Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia
- (2021) Sophie E. Legge et al. JAMA Psychiatry
- Predicting time to relapse in patients with schizophrenia according to patients’ relapse history: a historical cohort study using real-world data in Sweden
- (2021) Kristian Tore Jørgensen et al. BMC Psychiatry
- Confounding of Antipsychotic Discontinuation Studies by Withdrawal-Related Relapse
- (2021) Mark Abie Horowitz et al. SCHIZOPHRENIA BULLETIN
- The nature of schizophrenia: As broad as it is long
- (2021) Michael J. Owen et al. SCHIZOPHRENIA RESEARCH
- To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
- (2020) Marieke J. H. Begemann et al. Trials
- Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features
- (2020) Aristotle N. Voineskos et al. JAMA Psychiatry
- Digital phenotyping of negative symptoms: the relationship to clinician ratings
- (2020) Alex S Cohen et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis
- (2020) Lasse Brandt et al. Frontiers in Psychiatry
- Antipsychotics and mortality – more clarity needed
- (2020) David Taylor et al. PSYCHOLOGICAL MEDICINE
- What is Missing in Treatment Guidelines?
- (2020) William T Carpenter SCHIZOPHRENIA BULLETIN
- Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
- (2019) Dag Alnæs et al. JAMA Psychiatry
- Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode
- (2019) Jolanta Zanelli et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacological treatment of violence in schizophrenia
- (2019) Martin T. Strassnig et al. CNS SPECTRUMS
- From Many to One to Many—the Search for Causes of Psychiatric Illness
- (2019) Kenneth S. Kendler JAMA Psychiatry
- Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review
- (2019) Joanna Moncrieff et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms
- (2019) Yutaro Shimomura et al. SCHIZOPHRENIA RESEARCH
- 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
- (2018) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Very long-term outcome of schizophrenia
- (2018) Jan Volavka et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?
- (2018) Jan Józef Szczypiński et al. REVIEWS IN THE NEUROSCIENCES
- The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention
- (2018) Anthony A Grace et al. SCHIZOPHRENIA BULLETIN
- A critical analysis of recent data on the long-term outcome of antipsychotic treatment
- (2018) Joanna Moncrieff et al. PSYCHOLOGICAL MEDICINE
- Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis
- (2017) Sanna Huhtaniska et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort
- (2017) Anja P. Husa et al. PSYCHIATRY RESEARCH
- Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis
- (2017) Regitze Sølling Wils et al. SCHIZOPHRENIA RESEARCH
- Secondary negative symptoms — A review of mechanisms, assessment and treatment
- (2017) Matthias Kirschner et al. SCHIZOPHRENIA RESEARCH
- Research on a ‘drug-centred’ approach to psychiatric drug treatment: assessing the impact of mental and behavioural alterations produced by psychiatric drugs
- (2017) J. Moncrieff Epidemiology and Psychiatric Sciences
- Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia
- (2017) Christoph U. Correll et al. JAMA Psychiatry
- Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- Genetic correlates of insight in schizophrenia
- (2017) Rose Mary Xavier et al. SCHIZOPHRENIA RESEARCH
- Cognitive biases associated with medical decisions: a systematic review
- (2016) Gustavo Saposnik et al. BMC Medical Informatics and Decision Making
- Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
- (2016) Robin M. Murray et al. BRITISH JOURNAL OF PSYCHIATRY
- Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era
- (2016) M. Alvarez-Jimenez et al. CNS DRUGS
- Long-term antipsychotic use and its association with outcomes in schizophrenia – the Northern Finland Birth Cohort 1966
- (2016) J.M. Moilanen et al. EUROPEAN PSYCHIATRY
- Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
- (2015) Pál Czobor et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Nation-Wide Study on the Percentage of Schizophrenia and Bipolar Disorder Patients Who Earn Minimum Wage or Above
- (2015) Michael Davidson et al. SCHIZOPHRENIA BULLETIN
- Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function
- (2015) Joyce Y. Guo et al. SCHIZOPHRENIA RESEARCH
- Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication
- (2014) Juha Veijola et al. PLoS One
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
- (2014) C. Morgan et al. PSYCHOLOGICAL MEDICINE
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Insight and Hostility as Predictors and Correlates of Nonadherence in the European First Episode Schizophrenia Trial
- (2013) Pál Czobor et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
- (2013) P. Fusar-Poli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?
- (2013) M. Harrow et al. SCHIZOPHRENIA BULLETIN
- Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
- (2013) Stephen R. Marder et al. SCHIZOPHRENIA RESEARCH
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Antipsychotics: is it time to introduce patient choice?
- (2012) Anthony P. Morrison et al. BRITISH JOURNAL OF PSYCHIATRY
- A Randomized Trial Comparing In Person and Electronic Interventions for Improving Adherence to Oral Medications in Schizophrenia
- (2012) D. Velligan et al. SCHIZOPHRENIA BULLETIN
- Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
- (2012) Robin Emsley et al. SCHIZOPHRENIA RESEARCH
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Long-term Antipsychotic Treatment and Brain Volumes
- (2011) Beng-Choon Ho et al. ARCHIVES OF GENERAL PSYCHIATRY
- Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode Schizophrenia
- (2011) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- Clinical relevance of findings in trials of antipsychotics: systematic review
- (2011) Peter Lepping et al. BRITISH JOURNAL OF PSYCHIATRY
- Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern Finland 1966 Birth Cohort study
- (2011) J. Moilanen et al. EUROPEAN PSYCHIATRY
- Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
- (2009) Michael Davidson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
- (2009) Julie Kreyenbuhl et al. SCHIZOPHRENIA BULLETIN
- Side-effects of antipsychotic medication and health-related quality of life in schizophrenia
- (2008) P. E. Bebbington et al. ACTA PSYCHIATRICA SCANDINAVICA
- Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
- (2008) Anne-Noël Samaha et al. BIOLOGICAL PSYCHIATRY
- Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia
- (2008) S. Mohamed et al. SCHIZOPHRENIA BULLETIN
- Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI
- (2007) Stephen Z. Levine et al. SCHIZOPHRENIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started